BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36042375)

  • 1. MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis.
    Gan J; Liu S; Zhang Y; He L; Bai L; Liao R; Zhao J; Guo M; Jiang W; Li J; Li Q; Mu G; Wu Y; Wang X; Zhang X; Zhou D; Lv H; Wang Z; Zhang Y; Qian C; Feng M; Chen H; Meng Q; Huang X
    Exp Mol Med; 2022 Aug; 54(8):1290-1305. PubMed ID: 36042375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting Castration-Resistant Prostate Cancer Using Mesenchymal Stem Cell Exosomes for Therapeutic MicroRNA-let-7c Delivery.
    Kurniawati I; Liu MC; Hsieh CL; Do AD; Sung SY
    Front Biosci (Landmark Ed); 2022 Sep; 27(9):256. PubMed ID: 36224011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GR silencing impedes the progression of castration-resistant prostate cancer through the JAG1/NOTCH2 pathway via up-regulation of microRNA-143-3p.
    Zhang L; Jiang H; Zhang Y; Wang C; Xia X; Sun Y
    Cancer Biomark; 2020; 28(4):483-497. PubMed ID: 32568179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55.
    You B; Zhang KC
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7660-7670. PubMed ID: 30536308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.
    Gao F; Xu Q; Tang Z; Zhang N; Huang Y; Li Z; Dai Y; Yu Q; Zhu J
    J Transl Med; 2022 Aug; 20(1):346. PubMed ID: 35918733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of miR-3195, miR-3687 and miR-4417 is associated with castration-resistant prostate cancer.
    Rönnau CGH; Fussek S; Smit FP; Aalders TW; van Hooij O; Pinto PMC; Burchardt M; Schalken JA; Verhaegh GW
    World J Urol; 2021 Oct; 39(10):3789-3797. PubMed ID: 33990872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crocin induces ROS-mediated papillary thyroid cancer cell apoptosis by modulating the miR-34a-5p/PTPN4 axis in vitro.
    Tang Y; Yang H; Yu J; Li Z; Xu Q; Ding B; Jia G
    Toxicol Appl Pharmacol; 2022 Feb; 437():115892. PubMed ID: 35085590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
    Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
    Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long Non-coding RNA AFAP1-AS1 Facilitates Prostate Cancer Progression by Regulating miR-15b/IGF1R Axis.
    Liu B; Jiang HY; Yuan T; Zhou WD; Xiang ZD; Jiang QQ; Wu DL
    Curr Pharm Des; 2021; 27(41):4261-4269. PubMed ID: 34126893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis.
    Zhang Y; Zhao J; Ding M; Su Y; Cui D; Jiang C; Zhao S; Jia G; Wang X; Ruan Y; Jing Y; Xia S; Han B
    J Exp Clin Cancer Res; 2020 Dec; 39(1):282. PubMed ID: 33317606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p/IGF1R axis.
    Jiang S; Chen H; He K; Wang J
    Bioengineered; 2022 Feb; 13(2):2004-2016. PubMed ID: 35030978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2.
    Jiang S; Mo C; Guo S; Zhuang J; Huang B; Mao X
    J Exp Clin Cancer Res; 2019 Dec; 38(1):495. PubMed ID: 31847864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.
    Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D
    Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
    Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Mol Oncol; 2019 Feb; 13(2):322-337. PubMed ID: 30444038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Berbamine targets cancer stem cells and reverses cabazitaxel resistance via inhibiting IGF2BP1 and p-STAT3 in prostate cancer.
    Wang L; Lyu C; Stadlbauer B; Buchner A; Nößner E; Pohla H
    Prostate; 2024 Feb; 84(2):131-147. PubMed ID: 37828768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
    Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
    Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
    Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
    Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
    J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of PTPN4 activates STAT3 to promote the tumor growth in rectal cancer.
    Zhang BD; Li YR; Ding LD; Wang YY; Liu HY; Jia BQ
    Cancer Sci; 2019 Jul; 110(7):2258-2272. PubMed ID: 31025789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-183 promotes migration and invasion of CD133(+)/CD326(+) lung adenocarcinoma initiating cells via PTPN4 inhibition.
    Zhu C; Deng X; Wu J; Zhang J; Yang H; Fu S; Zhang Y; Han Y; Zou Y; Chen Z; Lin S
    Tumour Biol; 2016 Aug; 37(8):11289-97. PubMed ID: 26951513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.